Сто осемдесет и шест пациентки са рандомизирани да получават доцетаксел (100 mg/ m2) с или без трастуцумаб; 60% от
One hundred eighty six patients were randomized to receive docetaxel (100 mg/ m2) with or without trastuzumab; 60% of patients received prior anthracycline-based adjuvant chemotherapy.